Searched query = "Idiopathic interstitial pneumonia", "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual interstitial pneumonia", "UIP", "Non-specific interstitial pneumonia", "NSIP", "Acute interstitial pneumonia", "AIP", "Diffuse alveolar damage", "DAD", "COP", "Organizing pneumonia", "OP", "Desquamative interstitial pneumonia", "DIP", "Respiratory bronchiolitis - associated interstitial lung disease", "RB-ILD", "Lymphocytic interstitial pneumonia", "LIP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|December 31, 2020||21/8/2020||Safety and Effectiveness of Nintedanib in Korean Patients||A Regulatory Required Non-interventional Study to Monitor the Safety and Effectiveness of Ofev(Nintedanib 150mg/100mg BID) in Korean Patients||Idiopathic Pulmonary Fibrosis||Drug: Nintedanib||Boehringer Ingelheim||NULL||Not yet recruiting||N/A||N/A||All||3000||Korea, Republic of|
|December 2013||1/12/2013||The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis||Observational Study of the Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis||Idiopathic Pulmonary Fibrosis||Other: Cough monitor||Erasmus Medical Center||University of Catania;University of Lyon;King's College Hospital NHS Trust;Royal Brompton & Harefield NHS Foundation Trust||Completed||40 Years||85 Years||Both||43||N/A||France;Italy;Netherlands|